Compare Hewlett Packard Enterprise Co (HPE) vs Eli Lilly And Co (LLY) Price & Performance

HPE trades at $46.73, up 1.99% today, with a bullish technical signal and strong recent earnings beats. The stock is supported by a $6.3 billion AI backlog and a strategic shift toward high-margin networking, which now drives 44% of segment profit. Revenue grew to $34.3 billion in 2025, though net income fell sharply to $57 million due to heavy investment. Analysts maintain a consensus price target of $69.69, implying significant upside.

Outlook is positive given AI infrastructure demand and networking momentum, but risks include execution on large investments, competitive pressures, and volatile cash flows. The stock offers growth potential if margin expansion continues, yet investors must monitor debt levels and earnings consistency amid macroeconomic uncertainty.

Eli Lilly (LLY) trades at $1,175.15, down 0.33% on the day, with a bullish technical signal and strong fundamental momentum. Revenue surged to $65.18B in 2025, with net income reaching $20.64B, and the company has beaten earnings estimates for three consecutive quarters. Recent news includes a lawsuit from Novo Nordisk over weight-loss drug advertising, but analyst sentiment remains overwhelmingly positive with a $1,380 consensus price target.

Outlook is supported by robust earnings growth and high profitability margins, but risks include competitive pressures and elevated valuation multiples. The stock's current price is near key resistance at $1,174, with institutional buying activity indicating continued confidence in Lilly's growth trajectory in the pharmaceutical sector.